Prostate
Cancer
Drug dramatically shrinks Prostate Tumors, study finds - July 23, 2008
There is a general sense in the prostate cancer community that this agent is
extremely promising and is very likely to have an important role in the
management of prostate cancer patients,' said Dr. Howard M. Sandler, a
radiation oncologist at the University of Michigan who is a spokesman for the
American Society of Clinical Oncology.'It's pretty safe to say that we are
going to have a lot more to offer patients when this drug gets approved,' added
Dr. Robert Reiter, a urologist at UCLA's Jonsson Comprehensive Cancer Center
who was not involved in the research.
Radiation
helps even when Prostate Cancer returns - June 17, 2008
Radiation therapy can help prolong the lives of men with aggressive prostate
cancer whose tumors return after surgery, U.S. researchers said on Tuesday.
Radiation therapy given within two years of recurrence cut the risk of dying
from prostate cancer by two-thirds, compared with those who got no additional
treatment, they said.
Prostate-screening exams may miss cancer in obese patients, study shows
- November 27, 2007
Higher blood volumes probably cause lower concentrations of prostate-specific
antigen, or PSA, in obese prostate cancer patients, reports a study, leading
the authors to speculate screening with PSA tests might miss some cancers in
obese men.
Study Supports Change to Prostate Cancer Biopsy -
October 2, 2007
Adding an extra step to the standard test for prostate cancer might improve
treatment for some men, a new study finds.